Rockwell Medical, Inc.
General ticker "RMTI" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $45.3M (TTM average)
Rockwell Medical, Inc. follows the US Stock Market performance with the rate: 9.3%.
Estimated limits based on current volatility of 3.1%: low 0.90$, high 0.96$
Factors to consider:
- Total employees count: 237 as of 2023
- Top business risk factors: Limited resources, Operational and conduct risks, Contract risk with largest customer, Regulatory and compliance, Economic downturns and volatility
- Price in estimated range
- Earnings for 12 months up through Q4 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.13$, 3.30$]
- 2025-12-31 to 2026-12-31 estimated range: [0.83$, 2.55$]
Financial Metrics affecting the RMTI estimates:
- Positive: with PPE of 105.4 at the end of fiscal year the price was very low
- Positive: -4.75 < Operating profit margin, % of 0.60
- Positive: Industry inventory ratio change (median), % of -1.45 <= -0.16
- Positive: -3.43 < Return on assets ratio (scaled to [-100,100]) of -0.80
- Positive: -14.22 < Investing cash flow per share per price, % of -7.43
Short-term RMTI quotes
Long-term RMTI plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $72.81MM | $83.61MM | $101.49MM |
| Operating Expenses | $89.59MM | $90.28MM | $100.88MM |
| Operating Income | $-16.78MM | $-6.67MM | $0.61MM |
| Non-Operating Income | $-1.90MM | $-1.77MM | $-1.09MM |
| Interest Expense | $1.94MM | $2.30MM | $1.25MM |
| R&D Expense | $3.12MM | $1.11MM | $0.02MM |
| Income(Loss) | $-18.68MM | $-8.44MM | $-0.48MM |
| Profit(Loss)* | $-18.68MM | $-8.44MM | $-0.48MM |
| Stockholders Equity | $14.11MM | $21.29MM | $32.59MM |
| Inventory | $5.81MM | $5.87MM | $5.78MM |
| Assets | $46.63MM | $52.17MM | $59.21MM |
| Operating Cash Flow | $-16.93MM | $-9.41MM | $4.20MM |
| Capital expenditure | $0.28MM | $0.28MM | $1.01MM |
| Investing Cash Flow | $-2.40MM | $-3.04MM | $-4.87MM |
| Financing Cash Flow | $16.15MM | $11.34MM | $7.35MM |
| Earnings Per Share** | $-1.89 | $-0.36 | $-0.02 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.